Sale!

CALCRL Gene Vascular System Defects NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The CALCRL Gene Vascular System Defects NGS Genetic DNA Test is a cutting-edge genetic diagnostic tool that identifies mutations in the CALCRL gene responsible for vascular system abnormalities. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect CALCRL deficiency, which can lead to serious cardiovascular and circulatory disorders. The test is particularly important for individuals with family history of vascular diseases, unexplained vascular malformations, or congenital heart defects. Results provide crucial information for personalized treatment strategies and family planning decisions. The test is available for $500 USD (discounted from $700 USD) and provides results within 3-4 weeks using blood, extracted DNA, or blood spot samples.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

CALCRL Gene Vascular System Defects NGS Genetic DNA Test

Comprehensive Genetic Analysis for Vascular Health

The CALCRL Gene Vascular System Defects NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for vascular disorders. This advanced test specifically targets the CALCRL (Calcitonin Receptor-Like Receptor) gene, which plays a critical role in vascular development and function. CALCRL deficiency can lead to significant vascular system abnormalities, making early detection essential for proper management and treatment planning.

What Does the CALCRL Gene Test Measure?

This sophisticated genetic test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the CALCRL gene for mutations and variations that may cause vascular system defects. The test specifically detects:

  • Pathogenic variants in the CALCRL gene sequence
  • Mutations affecting calcitonin receptor-like receptor function
  • Genetic alterations impacting vascular development pathways
  • Inherited patterns of CALCRL deficiency
  • Risk factors for vascular malformations and cardiovascular complications

Who Should Consider This Genetic Test?

Clinical Indications and Symptoms

This test is recommended for individuals experiencing or with family history of:

  • Unexplained vascular malformations or abnormalities
  • Congenital heart defects with unknown genetic causes
  • Family history of vascular system disorders
  • Recurrent cardiovascular complications without clear etiology
  • Developmental delays associated with circulatory issues
  • Multiple family members with similar vascular conditions
  • Unexplained arterial or venous abnormalities
  • Suspected genetic predisposition to vascular diseases

Benefits of CALCRL Genetic Testing

Undergoing the CALCRL Gene Vascular System Defects NGS Genetic DNA Test provides numerous advantages:

  • Accurate Diagnosis: Provides definitive genetic confirmation of CALCRL-related vascular disorders
  • Personalized Treatment: Enables targeted therapeutic approaches based on specific genetic findings
  • Family Planning: Offers valuable information for reproductive decisions and genetic counseling
  • Early Intervention: Facilitates proactive management strategies before severe complications develop
  • Comprehensive Analysis: Utilizes advanced NGS technology for thorough genetic assessment
  • Risk Assessment: Helps identify at-risk family members for preventive monitoring

Understanding Your Test Results

Your CALCRL genetic test results will be carefully interpreted by our expert genetic counselors and medical professionals:

  • Positive Result: Indicates the presence of pathogenic CALCRL gene mutations, confirming genetic predisposition to vascular system defects
  • Negative Result: Suggests no detectable CALCRL mutations, though other genetic factors may still be involved
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications requiring further evaluation
  • Carrier Status: Determines if you carry a single copy of a mutated gene that could be passed to offspring

All results include comprehensive genetic counseling to help you understand the implications and next steps for your health management.

Test Pricing and Details

Test Component Details
Test Name CALCRL Gene Vascular System Defects NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before undergoing the CALCRL genetic test, patients should provide:

  • Complete clinical history relevant to vascular system concerns
  • Participation in a genetic counseling session
  • Development of a detailed pedigree chart documenting family members affected by vascular disorders
  • Informed consent understanding the test implications and potential outcomes

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic testing facilities ensures consistent, high-quality service regardless of your location.

Take Control of Your Vascular Health Today

Don’t let uncertainty about your vascular health create unnecessary anxiety. The CALCRL Gene Vascular System Defects NGS Genetic DNA Test provides the clarity and confidence you need for informed healthcare decisions. Our team of genetic specialists is ready to guide you through the testing process and help interpret your results for optimal health management.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your CALCRL genetic test. Take the first step toward understanding your vascular health with precision genetic testing.